Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment
23rd January 2025 Uncategorised 0
Orphan drug designation offers development incentives and potential market exclusivity

More: Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment
Source: News
